NCT02023268View on ClinicalTrials.gov

Efficacy and Safety of T2762 and Vismed® in Dry Eye Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

February 28, 2015

Conditions
Dry Eye Syndrome
Interventions
DEVICE

T2762

1 drop in each eye 3 to 6 times daily during 84 days

DEVICE

Vismed®

1 drop in each eye 3 to 6 times daily during 84 days

Trial Locations (1)

Unknown

Clermont-Ferrand

Sponsors

Lead Sponsor

Laboratoires Thea
All Listed Sponsors
lead

Laboratoires Thea

INDUSTRY